Last updated on April 2018

Biomarker Establishment for Superior Treatment of PTSD

Brief description of study

The purpose of Biomarker Establishment for Superior Treatment of PTSD is to accelerate research on the discovery of biological, neurological and neuroimaging markers for PostTraumatic Stress Disorder (PTSD). The investigators hope to validate and extend the network efficiency and verbal memory biomarker for PTSD. The investigators hope to learn whether there are pretreatment biological factors that can predict response to therapy. They want to do this by understanding the brain network function, relating EEG to functional magnetic resonance imaging, and application of network analysis tool.

Clinical Study Identifier: NCT03343028

Contact Investigators or Research Sites near you

Start Over

Jillian Autea, MPA

VA Palo Alto Health Care System (VAPAHCS)
Palo Alto, CA United States
  Connect »

Madeleine Goodkind, PhD

New Mexico VA Health Care System
Albuquerque, NM United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.